Greenoaks is a global investment firm specializing in technology companies.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 345 California Street
City: San Francisco
State: CA
Zip: 94104
Country: US
Greenoaks makes long-term, concentrated investments in technology-enabled businesses globally. Greenoaks investments include Clover Health, Robinhood, and Katerra in the US, Coupang in South Korea, Deliveroo in the UK, and Flipkart and Oyo Rooms in India. It was founded in 2012 and is based in San Francisco, California, United States.
Contact Phone:
+14157724000
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2022 | StarkWare Industries | Series D | 100M |
3/2022 | Linktree | Series C | 110M |
11/2021 | Buf | Series B | 68M |
12/2014 | Coupang | Private Equity Round | 300M |
10/2018 | ONE Championship | Series D | 166M |
3/2022 | Melange Technologies, Inc. | Seed Round | 7.6M |
8/2022 | Superblocks | Series A | 37M |
10/2021 | Wiz | Series C | 250M |
4/2021 | Cora | Series A | 26.7M |
10/2021 | Personio | Series E | 270M |
5/2014 | Coupang | Venture Round | 100M |
12/2018 | Alto Pharmacy | Series C | 50M |
3/2022 | Payhawk | Series B | 0 |
10/2021 | Rippling | Series C | 250M |
4/2021 | Scale AI | Series E | 325M |
2/2022 | Hasura | Series C | 0 |
9/2021 | Neo Financial | Series B | 0 |
8/2020 | Rippling | Series B | 145M |
1/2022 | flex | Series B | 32M |
9/2021 | Commure | Series D | 500M |
10/2020 | Tipalti | Series E | 150M |
4/2017 | Katerra | Series C | 0 |
12/2021 | Outerbounds | Series A | 18.5M |
1/2021 | Exafunction | Seed Round | 3M |
6/2019 | Misfits Market | Series A | 16.5M |
10/2021 | Buk | Series A | 0 |
12/2019 | Zetwerk | Series B | 32M |
3/2021 | Viz | Series C | 71M |
1/2021 | TripActions | Series E | 155M |
3/2017 | Sonder | Series B | 32M |
1/2021 | Checkout.com | Series C | 450M |
8/2021 | Databricks | Series H | 1.6B |
12/2020 | Discord | Series H | 100M |
12/2021 | Cockroach Labs | Series F | 0 |
6/2020 | Navan | Debt Financing | 125M |
2/2021 | Databricks | Series G | 1B |
10/2021 | Navan | Series F | 275M |
4/2021 | CRED | Series D | 214.7M |
8/2021 | Databricks | Series H | 0 |
1/2020 | Alto Pharmacy | Series D | 0 |
1/2021 | Cockroach Labs | Series E | 160M |
4/2019 | Motive | Series D | 149M |
2/2021 | Zetwerk | Series D | 120M |
2/2023 | Wiz | Series D | 0 |
10/2021 | Gorillas | Series C | 0 |
7/2020 | Zetwerk | Series C | 21M |
11/2021 | Payhawk | Series B | 0 |
2/2023 | Temporal Technologies | Series B | 0 |
5/2022 | Motive | Series F | 0 |
6/2022 | WorkOS | Series B | 80M |
3/2021 | Compound | Series A | 10M |
6/2020 | Sonder | Series E | 170M |
12/2022 | Synchron | Series C | 75M |
7/2022 | Casavo | Series D | 0 |
1/2022 | Compound | Series B | 0 |
9/2021 | Canva | Venture Round | 200M |
9/2022 | Mysten Labs | Series B | 0 |
4/2022 | Exafunction | Series A | 25M |
12/2018 | Discord | Series F | 0 |
8/2021 | QuintoAndar | Series E | 120M |
1/2022 | Turnip | Series A | 0 |
3/2021 | Wiz | Series B | 130M |
1/2022 | FTX US | Series A | 0 |
5/2019 | Deliveroo | Series G | 575M |
1/2019 | Clover Health | Series E | 500M |
11/2021 | Pigment | Series B | 73M |
2/2023 | Buk | Venture Round | 0 |
7/2020 | Misfits Market | Series B | 85M |
9/2019 | Kavak | Series B | - |
12/2021 | Supergreat | Series B | 20M |
3/2021 | Gorillas | Series B | 290M |
9/2021 | Cider | Series B | 130M |
4/2017 | Robinhood | Series C | 110M |
5/2016 | Clover Health | Series C | 160M |
11/2022 | Cloud Health Systems | Series A | 0 |
4/2022 | Studio | Series B | 0 |
4/2022 | Inventa | Series B | 0 |
6/2020 | TripActions | Debt Financing | 125M |
10/2021 | TripActions | Series F | 275M |
4/2021 | Misfits Market | Series C | 200M |
12/2021 | Zetwerk | Series F | 0 |
3/2021 | Airwallex | Series D | 0 |
12/2021 | Airtable | Series F | 0 |
8/2021 | Zetwerk | Series E | 150M |
10/2019 | Casavo | Series B | 55.1M |
9/2020 | Kavak | Series C | 385M |
6/2019 | Brex | Series C | 100M |
8/2021 | Cora | Series B | 116.3M |
6/2017 | Alto Pharmacy | Series B | 17M |
10/2019 | Viz | Series B | 50M |
3/2021 | Airtable | Series E | 270M |
5/2017 | Clover Health | Series D | 130M |
3/2021 | Casavo | Series C | 59.9M |
5/2021 | Agicap | Series B | 100M |
6/2021 | Vercel | Series C | 102M |
11/2021 | Vercel | Series D | 0 |
7/2019 | Sonder | Series D | 0 |
2/2021 | Ally.io | Series C | 50M |
10/2021 | Brex | Series D | 300M |
8/2016 | Deliveroo | Series E | 275M |
1/2022 | Inventa | Series A | 0 |
2/2015 | OYO | Series A | 25M |
4/2021 | Motive | Series E | 190M |
11/2015 | Deliveroo | Series D | 100M |
8/2018 | Sonder | Series C | 0 |
1/2022 | Athelas | Venture Round | 59.4M |
3/2022 | Linktree | Series C | 110M |
2/2022 | Zebec Protocol | Series A | 0 |
9/2021 | Papaya Global | Series D | 250M |
7/2015 | Deliveroo | Series C | 70M |
3/2021 | Papaya Global | Series C | 0 |
6/2022 | Personio | Series E | 0 |
2/2020 | Toast | Series F | 0 |
4/2021 | Brex | Series D | 425M |
12/2020 | Vercel | Series B | 40M |
7/2022 | Casavo | Series D | 0 |
6/2022 | Personio | Series E | 0 |
6/2022 | WorkOS | Series B | 0 |
5/2022 | StarkWare Industries | Series D | 0 |
5/2022 | Motive | Series F | 0 |
4/2022 | Exafunction | Series A | 0 |
4/2022 | Inventa | Series B | 0 |
4/2022 | Studio | Series B | 0 |
3/2022 | Linktree | Grant | 0 |
3/2022 | Payhawk | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|